Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

Core Insights - Lifecore Biomedical, Inc. will report its financial results for the second quarter of fiscal year 2025 on January 2, 2025, after market close [1] - A webcast will be hosted by Lifecore's senior management team at 4:30 p.m. Eastern Time on the same day to discuss the financial results and recent corporate developments [1] Company Overview - Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development, fill, and finish of sterile injectable pharmaceutical products, including complex formulations [3] - The company has over 40 years of expertise in manufacturing premium, injectable-grade hyaluronic acid and partners with global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories [3]